BioGaia AB (publ)
The answer first
Does BioGaia beat the market?
Yes, BioGaia has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 72% of Nordic stocks
- Quality100
- Value9
- Trend77
No. 36 of 195 in healthcare
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash BioGaia keeps must grow about 18% a year for 10 years.
Max for seven days
Follow BioGaia with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about BioGaia
Your first answer is free, no account needed.
Do you own BioGaia, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with BioGaia and a few more. Free, no card.
Super Stock+46.3%In short
- BioGaia has risen 29.1% over the past year, including dividends.
- Overall, BioGaia ranks better than 72% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 29.3%. The price is 6.7% below its peak now.
What do analysts think of BioGaia?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 72% of Nordic stocks.
No. 36 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 2 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.01
- Asset turnoverSales divided by everything the company owns1.14
- Return on equityProfit divided by equity+32.0%
- Cash conversionOperating cash flow divided by profit0.73
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 139 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity10.2
- P/SPrice divided by sales7.6
- P/EPrice divided by earnings31.9
- P/CFPrice divided by operating cash flow43.9
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 46 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+8.2%
- 6 months−1.5%
- 9 months+20.8%
- 12 months+29.1%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own BioGaia
39 funds we follow own BioGaia. The share is how much of the fund the stock makes up.
- Norway1
- Sweden38
- 1 ETF
- TIN Ny Teknik FSweden · TIN6.4%
- FIRST Veritas A SEKSweden · FIRST5.2%
- Case Gaia MicrocapSweden · Case4.4%
- Case All StarSweden · Case3.3%
- PLUS Hälsovård Sverige IndexSweden · PLUS3.3%
- TIN Småbolag ASweden · TIN3.2%
- Aktiespararna Småbolag EdgeSweden · Aktiespararna2.7%
- Simplicity Småbolag Sverige ASweden · Simplicity2.3%
Show all 39
- Enter Småbolagsfond ASweden · Enter1.8%
- Didner & Gerge SmåbolagSweden · Didner1.6%
- AMF Aktiefond SmåbolagSweden · AMF1.3%
- Öhman Sweden Micro Cap ASweden · Öhman1.2%
- Länsförsäkringar Småbolag Sverige ASweden · Länsförsäkringar1.0%
- Öhman Sverige Hållbar ASweden · Öhman1.0%
- Lysa Sverige Aktier BSweden · Lysa0.9%
- Kvartil Nordiska Småbolag+ Faktor ASweden · Kvartil0.7%
- Handelsbanken Europa Småbolag (A1 NOK)Sweden · Handelsbanken0.5%
- Handelsbanken Europa Småbolag A10 NOKSweden · Handelsbanken0.5%
- Lärarfond 21-44 årSweden · Lärarfond0.5%
- Xact Svenska Småbolag (UCITS ETF)Sweden · XACT · ETF0.4%
- Skandia Småbolag Sverige Exponering ASweden · Skandia0.4%
- Lärarfond 45-58 årSweden · Lärarfond0.4%
- PLUS Småbolag Sverige IndexSweden · PLUS0.3%
- Avanza Sweden All Cap ASweden · Avanza0.2%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.2%
- Lärarfond 59+Sweden · Lärarfond0.2%
- Skandia Sverige ExponeringSweden · Skandia0.1%
- Simplicity SverigeSweden · Simplicity0.1%
- Öhman Etisk Index Sverige ASweden · Öhman0.1%
- PLUS Allabolag Sverige IndexSweden · PLUS0.1%
- KLP AksjeNorden IndeksNorway · KLP0.1%
- Skandia Världen SverigeSweden · Skandia0.1%
- Nordea Avtalspensionsfond MidiSweden · Nordea0.0%
- Handelsbanken Gl Småbolag I Crit A9 EURSweden · Handelsbanken0.0%
- Handelsbanken Gl Småbolag Ind Cri A1 NOKSweden · Handelsbanken0.0%
- Nordea Stratega 30Sweden · Nordea0.0%
- Nordea Stratega 50Sweden · Nordea0.0%
- Nordea Stratega 70Sweden · Nordea0.0%
- Skandia SMART FörsiktigSweden · Skandia0.0%
From the funds' latest known holdings.
About BioGaia
BioGaia AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 250 employees.
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product.


See the full analysis of BioGaia.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card